Lensmarket.bg offers a variety of contact lenses, including daily, monthly, and specialty lenses, along with care solutions, tailored for users' specifications.

Lensmarket.bg

LaserView is involved in eye surgery services, self-described as a reference in this field.

LaserView

成都爱迪眼科医院 is a national level three eye hospital that focuses on various eye diseases and corrective procedures.

成都爱迪眼科医院

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Metric
Company Name	Lensmarket.bg	LaserView	成都爱迪眼科医院
Symbol
MSH ID	BG:LENSMARKET	BR:COM:LASERVIEW	COM:028AIDI
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Consumer Goods	Healthcare & Health Services	Healthcare & Health Services
Industry	Optical Retail	Medical Services	Healthcare
Country	BG	BR	CN
Stage
Employee Count
Website	lensmarket.bg	laserview.com.br	028aidi.com
LinkedIn	lensmarket-bg		%E6%88%90%E9%83%BD%E7%88%B1%E8%BF%AA%E7%9C%BC%E7%A7%91%E5%8C%BB%E9%99%A2%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	355.66K
Web Traffic Growth	-0.38
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BAUSCH

Bausch + Lomb Corporation

Last Close

19.81

22/11 21:00

Market Cap

6.89B

Beta: -

Volume Today

363.23K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue